In a significant shift for the UK’s life sciences sector, Syncona, the Wellcome Trust-backed FTSE 250 investment company, has revealed plans to implement an orderly wind-down of its portfolio assets.
Healthcare6- Page
177Articles
Britain is on course to become a “National Health State,” with half of all public spending reportedly set to be allocated to the NHS and social care by the end
The American private equity group KKR, in collaboration with Stonepeak Partners, has increased its bid to acquire Assura, the NHS landlord, raising its offer to £1.7 billion. This revised bid
The NHS is projected to miss its target of treating 92 per cent of patients needing routine operations within 18 weeks, despite a significant £30 billion budget boost outlined in
Doctors who have trained in Britain will gain priority access to NHS job placements under Labour’s newly proposed ten-year plan to overhaul the health service. Health Secretary Wes Streeting has
The £1.7 billion takeover scramble for Assura, Britain’s prominent primary healthcare property firm, has taken a heated turn. Major UK shareholders have openly rejected an acquisition attempt led by US
One of the largest healthcare organisations in the United States, United Health Group, is now the subject of a criminal investigation by the US Department of Justice. The investigation, overseen
President Donald Trump has issued an executive order aimed at tackling high drug prices in the United States, sparking concern and volatility across the global pharmaceutical industry. The announcement marks
Wes Streeting, the Health Secretary, has criticised junior doctors for moving forward with a strike ballot before the government has had the opportunity to present its pay offer. He argued
In a significant move towards modernising cancer diagnostics, the NHS has announced a £2.4 million investment in groundbreaking blood test technology capable of detecting 12 different types of cancer. The
Private clinics delivering NHS cataract surgery are under intense scrutiny amid allegations of artificially inflated costs, unnecessary operations, and questionable financial incentives offered to high-street optometrists. The Department of Health
Research suggests that thousands of lives could be saved and subsequent heart attacks or strokes prevented through the administration of two cost-effective medicines. The study, conducted jointly by Imperial College
British pharmaceutical giant AstraZeneca has secured NHS approval for its groundbreaking breast cancer drug capivasertib, marking a significant milestone in oncology treatment. The twice-daily tablet, developed in Cambridge, demonstrates remarkable
Revolutionary NHS Cancer Vaccine Trial Signals Fresh Hope for Investment in UK Healthcare Innovation
The National Health Service has unveiled a groundbreaking initiative, offering accelerated access to a pioneering cancer vaccine trial. This strategic move demonstrates the UK’s commitment to maintaining its position at
UK Government Accelerates Clinical Trials and Improves Access to NHS Data The United Kingdom government has unveiled ambitious plans aimed at enhancing the speed of clinical trials and facilitating greater
In a groundbreaking initiative aimed at addressing a multitude of social and health-related issues, an ambitious scheme is set to deploy an army of health workers door-to-door across various regions
